Atlas Brown’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $536K | Hold |
5,924
| – | – | 0.14% | 141 |
|
|
2026
Q1 | $474K | Hold |
5,924
| – | – | 0.14% | 138 |
|
|
2025
Q4 | $505K | Sell |
5,924
-40
| -0.7% | -$3.28K | 0.15% | 135 |
|
|
2025
Q3 | $464K | Buy |
5,964
+5
| +0.1% | +$391 | 0.14% | 137 |
|
|
2025
Q2 | $466K | Sell |
5,959
-505
| -8% | -$37.7K | 0.15% | 136 |
|
|
2025
Q1 | $469K | Hold |
6,464
| – | – | 0.16% | 130 |
|
|
2024
Q4 | $479K | Buy |
6,464
+15
| +0.2% | +$1.05K | 0.16% | 124 |
|
|
2024
Q3 | $426K | Buy |
6,449
+516
| +9% | +$37.5K | 0.15% | 135 |
|
|
2024
Q2 | $548K | Buy |
5,933
+15
| +0.3% | +$1.33K | 0.2% | 113 |
|
|
2024
Q1 | $566K | Buy |
5,918
+5
| +0.1% | +$420 | 0.21% | 107 |
|
|
2023
Q4 | $451K | Hold |
5,913
| – | – | 0.19% | 119 |
|
|
2023
Q3 | $410K | Hold |
5,913
| – | – | 0.19% | 119 |
|
|
2023
Q2 | $558K | Hold |
5,913
| – | – | 0.25% | 105 |
|
|
2023
Q1 | $489K | Hold |
5,913
| – | – | 0.23% | 112 |
|
|
2022
Q4 | $441K | Hold |
5,913
| – | – | 0.22% | 118 |
|
|
2022
Q3 | $489K | Hold |
5,913
| – | – | 0.25% | 113 |
|
|
2022
Q2 | $562K | Hold |
5,913
| – | – | 0.27% | 107 |
|
|
2022
Q1 | $696K | Buy |
5,913
+50
| +0.9% | +$5.61K | 0.28% | 107 |
|
|
2021
Q4 | $760K | Sell |
5,863
-500
| -8% | -$58.3K | 0.29% | 102 |
|
|
2021
Q3 | $720K | Hold |
6,363
| – | – | 0.31% | 99 |
|
|
2021
Q2 | $659K | Hold |
6,363
| – | – | 0.28% | 102 |
|
|
2021
Q1 | $532K | Hold |
6,363
| – | – | 0.25% | 109 |
|
|
2020
Q4 | $580K | Hold |
6,363
| – | – | 0.3% | 98 |
|
|
2020
Q3 | $508K | Hold |
6,363
| – | – | 0.3% | 89 |
|
|
2020
Q2 | $440K | Buy |
6,363
+363
| +6% | +$25.8K | 0.28% | 96 |
|
|
2020
Q1 | $377K | Hold |
6,000
| – | – | 0.29% | 96 |
|
|
2019
Q4 | $467K | Hold |
6,000
| – | – | 0.29% | 96 |
|
|
2019
Q3 | $440K | Hold |
6,000
| – | – | 0.31% | 94 |
|
|
2019
Q2 | $369K | Sell |
6,000
-1,002
| -14% | -$60.6K | 0.26% | 102 |
|
|
2019
Q1 | $447K | Hold |
7,002
| – | – | 0.32% | 89 |
|
|
2018
Q4 | $357K | Hold |
7,002
| – | – | 0.28% | 91 |
|
|
2018
Q3 | $406K | Hold |
7,002
| – | – | 0.25% | 99 |
|
|
2018
Q2 | $343K | Sell |
7,002
-552
| -7% | -$25.8K | 0.08% | 109 |
|
|
2018
Q1 | $351K | Sell |
7,554
-642
| -8% | -$27.9K | 0.06% | 106 |
|
|
2017
Q4 | $341K | Sell |
8,196
-96
| -1% | -$3.52K | 0.06% | 109 |
|
|
2017
Q3 | $302K | Buy |
+8,292
| New | +$316K | 0.06% | 105 |
|
Other funds holding EW
Atlas Brown's EW Position: Q2 2026 in Review
Atlas Brown held its Edwards Lifesciences (EW) position steady in Q2 2026 at 5,924 shares worth $536K. The position accounts for 0.14% of the portfolio, ranked #141.
Atlas Brown first reported a position in EW in Q3 2017 and has held it in 36 quarters since. The position peaked at $760K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Atlas Brown held 5,924 shares of Edwards Lifesciences worth $536K as of Q2 2026.
- Atlas Brown left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up 0.14% of Atlas Brown's portfolio in Q2 2026, its #141 holding.
- Atlas Brown first reported a position in Edwards Lifesciences in Q3 2017 and has held it in 36 quarters since.
- Atlas Brown's Edwards Lifesciences position peaked at $760K in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.